€0.244 -0.0 -1.6%
Last Trade - 09/04/21
Market Cap | £3.34m |
Enterprise Value | £10.1m |
Revenue | £18.1m |
Position in Universe | 711th / 730 |
April 16 (Reuters) - Bioera SpA BIE.MI : * REPORTED ON WEDNESDAY FY NET LOSS EUR 7.9 MLN VS LOSS EUR 4.1 MLN YEAR AGO * FY REVENUE EUR 30.2 MLN VS EUR 39.2 MLN YEAR AGO * ON COVID-19 CRISIS, CLOSURE OF SOME COMMERCIAL ACTIVITIES LED TO SHUTDOWN OF IMPORTANT PRODUCT DISTRIBUTION CHANNELS, WITH INEVITABLE REPERCUSSIONS ON TURNOVER TARGETS PREVIOUSLY FORSEEN. * ON COVID-19 CRISIS, GROUP ACTIVATED REDUNDANCY FUND PROCEDURES AND IS MONITORING ADDITIONAL EXTRAORDINARY MEASURES INTRODUCED BY GOVERNMENT * ON COVID-19 CRISIS, LENDERS APPROVED ONE-YEAR MPORATORIUM REQUESTS MADE BY GROUP ON EXISTING LOANS * SEES COMPLETION OF GENERAL REORGANIZATION OF GROUP ACTIVITIES IN 2020 Source text for Eikon: urn:newsml:reuters.com:*:nBIAbCJ8Mf Further company coverage: BIE.MI (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10))